Emilie Thivat

Summary

Affiliation: Centre Jean Perrin
Country: France

Publications

  1. pmc Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects
    Régine Minet-Quinard
    Clermont University, Universite d Auvergne, EA4233, LB2MN, CRNH A, BP10448, F 63000 Clermont Ferrand, France
    Immun Ageing 7:10. 2010
  2. pmc Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse
    Emilie Thivat
    Division of Clinical Research, Centre Jean Perrin, Clermont Ferrand, F 63011 France
    BMC Cancer 10:648. 2010
  3. doi request reprint Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, UMR 990, université Clermont 1, UFR Medecine, CIC 501, Clermont Ferrand, France
    Oncology 78:205-9. 2010
  4. doi request reprint Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy
    Xavier Durando
    Centre Jean Perrin, Universite d Auvergne, Clermont Ferrand, France
    Oncology 88:180-8. 2015
  5. doi request reprint Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, université Clermont 1, UFR Medecine, INSERM UMR 484, and Centre d Investigation Clinique, Clermont Ferrand, France
    Nutr Cancer 60:23-30. 2008
  6. doi request reprint A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)
    Philippe Chollet
    Centre Jean Perrin, Clermont Ferrand, France
    Cancer J 14:128-32. 2008

Collaborators

  • Marie Ange Mouret-Reynier
  • Henri Roche
  • Florence Dalenc
  • Frederique Penault-Llorca
  • Xavier Durando
  • Philippe Chollet
  • Catherine Abrial
  • Fabrice Kwiatkowski
  • Régine Minet-Quinard
  • Marie Chantal Farges
  • Marie Paule Vasson
  • Pauline Herviou
  • Edmond Rock
  • Caroline Petorin-Lesens
  • Denis Pezet
  • Gilles Mayot
  • Brigitte Winklhofer-Roob
  • Brigitte Gillet
  • Emmanuel Buc
  • M Chantal Farges
  • Josep Ribalta
  • Julius Brtko
  • M Paule Vasson
  • Cécile Deleine
  • Michel d'Incan
  • Aicha Demidem
  • Eric Cellarier
  • Chantal Barthomeuf
  • Marianne Leheurteur
  • Olivier Tacca
  • Frédérique Penault-Llorc
  • Jacques Dauplat

Detail Information

Publications6

  1. pmc Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects
    Régine Minet-Quinard
    Clermont University, Universite d Auvergne, EA4233, LB2MN, CRNH A, BP10448, F 63000 Clermont Ferrand, France
    Immun Ageing 7:10. 2010
    ..5 mg/kg/day during 28 days), whole blood cells were phenotyped, and functions of peripheral blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN) were investigated by flow cytometry and ELISA tests...
  2. pmc Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse
    Emilie Thivat
    Division of Clinical Research, Centre Jean Perrin, Clermont Ferrand, F 63011 France
    BMC Cancer 10:648. 2010
    ..Our study was aimed to evaluate the prognostic value of weight change during anthracycline-based chemotherapy on non metastatic breast cancer (European population) with a long term follow-up...
  3. doi request reprint Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, UMR 990, université Clermont 1, UFR Medecine, CIC 501, Clermont Ferrand, France
    Oncology 78:205-9. 2010
    ....
  4. doi request reprint Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy
    Xavier Durando
    Centre Jean Perrin, Universite d Auvergne, Clermont Ferrand, France
    Oncology 88:180-8. 2015
    ....
  5. doi request reprint Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial
    Xavier Durando
    Centre Jean Perrin, Unite de recherche clinique, université Clermont 1, UFR Medecine, INSERM UMR 484, and Centre d Investigation Clinique, Clermont Ferrand, France
    Nutr Cancer 60:23-30. 2008
    ..Based on these results, a Phase II clinical trial has been initiated to test the activity of the association of a 1-day MET-free diet with cystemustine treatment...
  6. doi request reprint A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)
    Philippe Chollet
    Centre Jean Perrin, Clermont Ferrand, France
    Cancer J 14:128-32. 2008
    ..Among the most useful are node involvement, tumor size, and pathologic grade. These factors retained their prognostic value when assessed after neoadjuvant chemotherapy...